MENU
+Compare
CLVLF
Stock ticker: OTC
AS OF
Aug 7 closing price
Price
$7.91
Change
-$0.09 (-1.12%)
Capitalization
399.67M

CLVLF Clinuvel Pharmaceuticals Ltd. Forecast, Technical & Fundamental Analysis

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria... Show more

CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLVLF with price predictions
Aug 08, 2025

Momentum Indicator for CLVLF turns negative, indicating new downward trend

CLVLF saw its Momentum Indicator move below the 0 level on August 07, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator turned negative. In of the 55 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CLVLF moved out of overbought territory on August 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for CLVLF turned negative on August 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for CLVLF entered a downward trend on July 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CLVLF advanced for three days, in of 36 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLVLF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.806) is normal, around the industry mean (18.662). P/E Ratio (15.878) is within average values for comparable stocks, (54.033). CLVLF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.004) settles around the average of (0.049) among similar stocks. P/S Ratio (6.693) is also within normal values, averaging (286.048).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLVLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLVLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

CLVLF paid dividends on September 17, 2021

Clinuvel Pharmaceuticals Ltd. CLVLF Stock Dividends
А dividend of $0.03 per share was paid with a record date of September 17, 2021, and an ex-dividend date of September 02, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
535 Bourke Street
Phone
+61 396604900
Employees
16
Web
https://www.clinuvel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHLYX33.250.20
+0.61%
Diamond Hill Large Cap Y
SGICX16.900.06
+0.36%
SGI US Large Cap Equity C
PGNAX56.880.14
+0.25%
PGIM Jennison Natural Resources A
LADPX21.21-0.02
-0.09%
Lord Abbett Developing Growth P
CTIGX15.54-0.11
-0.70%
Calamos Timpani SMID Growth I

CLVLF and Stocks

Correlation & Price change

A.I.dvisor tells us that CLVLF and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLF and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLF
1D Price
Change %
CLVLF100%
N/A
IONS - CLVLF
28%
Poorly correlated
+1.44%
MCRB - CLVLF
24%
Poorly correlated
-7.06%
PXXLF - CLVLF
23%
Poorly correlated
N/A
NICXF - CLVLF
22%
Poorly correlated
N/A
QNRX - CLVLF
22%
Poorly correlated
+3.47%
More